Process Scientist, Material and Analytical Sciences Co-Op
Boehringer Ingelheim
Summary
Boehringer Ingelheim is currently seeking a talented and innovative individual to join our Material and Analytical Sciences department located at our Ridgefield facility. As a Spring Co-Op, you will be working in a dynamic environment to develop novel critical material attributes to improve product performance through material characterization and mechanistic modeling platform.
Job description
Duties & Responsibilities
- Candidate will be involved in batch preparation of pharmaceutical granulation processes.
- Characterize various physical properties of drug substance, intermediates and drug products.
- Collect high quality data and summarize findings for department seminar.
Requirements
- Must be a current undergraduate, graduate or advanced degree student in good academic standing from Mechanical / Chemical / Material Engineering or pharmaceutical sciences background.
- Student must be enrolled at a college or university for the duration of the internship.
- Overall cumulative minimum GPA from last completed quarter/semester 3.0 GPA (on a 4.0 scale) preferred.
- Major or minor in related field of internship.
- Undergraduate students must have completed at least 12 credit hours at current college or university.
- Graduate and Advanced Degree students must have completed at least 9 credit hours at current college or university.
Desired Experience, Skills and Abilities
- Good understanding of material science and formulation development of small molecules including relevant characterization techniques is required.
- Knowledge of design of experiments (DOE) methodology and statistical analysis capabilities is essential.
- Fluency in Python/Matlab programming is preferred.
Eligibility Requirements
- Must be legally authorized to work in the United States without restriction.
- Must be willing to take a drug test and post-offer physical (if required).
- Must be 18 years of age or older.
Requirements
- Current undergraduate, graduate or advanced degree student in good academic standing
- Background in Mechanical / Chemical / Material Engineering or pharmaceutical sciences
- Enrolled at a college or university for the duration of the internship
- Major or minor in related field of internship
- Undergraduate students must have completed at least 12 credit hours at current college or university
- Graduate and Advanced Degree students must have completed at least 9 credit hours at current college or university
- Good understanding of material science and formulation development of small molecules including relevant characterization techniques
- Knowledge of design of experiments (DOE) methodology and statistical analysis capabilities
- Fluency in Python/Matlab programming preferred
- Must be legally authorized to work in the United States without restriction
- Must be 18 years of age or older
Benefits
- Medical Coverage
- Paid Time Off
- Paid Holidays
- Disability Insurance
- Life Insurance
- Company-Sponsored Benefits
Company overview
Boehringer Ingelheim is a leading global research-driven biopharmaceutical company founded in 1885 and headquartered in Ingelheim am Rhein, Germany. As one of the world's top 20 pharmaceutical companies and the largest privately-owned pharmaceutical firm, it operates across three main business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. The company focuses on developing innovative therapies for diseases with high unmet medical needs, including cardiometabolic diseases, oncology, respiratory diseases, immunology, central nervous system disorders, and retinal health. With over 54,500 employees across 78 countries, Boehringer Ingelheim generated approximately €26.8 billion in revenue in 2024. The company maintains a strong research and development network with facilities in Germany, the United States, Austria, Japan, and Switzerland, investing significantly in advancing treatments for both human and animal health. Notable products include Jardiance (empagliflozin) for diabetes, Ofev (nintedanib) for pulmonary fibrosis, Spiriva (tiotropium) for respiratory conditions, and Pradaxa (dabigatran) for anticoagulation therapy.